Navigation Links
VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
Date:12/4/2012

RADNOR, Pa., Dec. 4, 2012 /PRNewswire/ -- VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has acquired Labonord SAS and Switch BVBA, expanding the company's cytology and histology portfolio in Europe.

(Logo: http://photos.prnewswire.com/prnh/20101109/NY97837LOGO )

Based in Lille, France, Labonord is an independent supplier of consumables and chemicals and also represents a number of leading suppliers of histology products in France. Belgium-based Switch, a manufacturer of cytology and histology reagents and dyes, produces products under the Q-Path brand which are distributed through Labonord and an independent distribution partner and sold to customers in France, Belgium and the Netherlands.

"Labonord and Switch are recognized nationally throughout France and Belgium as trusted brands in the histology and cytology field," stated Manuel Brocke-Benz, CEO, Senior Vice President and Managing Director of European Operations. "This acquisition will enable VWR to expand its histology and cytology portfolio in these regions and provide opportunities to offer the Q-Path product across Europe. We welcome the Labonord and Switch teams to the VWR organization."

Financial details of this acquisition remain confidential.

About VWR International, LLC

VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $4.1 billion in 2011. VWR enables the advancement of the world's most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With over 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR, phone 1-800-932-5000, visit www.vwr.com, or write, VWR, Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087.

VWR and design are registered trademarks of VWR International, LLC.


'/>"/>
SOURCE VWR International, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Chindex International, Inc. to Report First Quarter 2012 Financial Results
4. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
7. SurgLine International, Inc. to Expand its Trauma Product Line With Completion of Acquisition
8. DATATRAK International, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
9. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. BioMed Diagnostics Microbiology Diagnostic Devices Now Available Worldwide Through Distribution Agreement With VWR International, LLC
11. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... PAUL, Minn. , July 20, 2017  Prime Therapeutics ... Jonathan Gavras , M.D., following today,s Institute for Clinical ... report on the effectiveness and value of abuse-deterrent ... manager on the policy roundtable at the meeting. ... is not a material cost benefit to the use of ...
(Date:7/15/2017)... 2017 Enterin Inc., a Philadelphia ... (PD), today announced the completion of a $12.7 million Series ... III, as well as the participation of existing investors. ... have the support of New Ventures III and our current ... of the potential of our platform technology to transform the ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... 24, 2017 , ... Anyone who uses scales know they have limits; a ... using that same scale to dispense medication. The first example is an issue of ... why it is important to have the right balance for the process. METTLER TOLEDO’s ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
(Date:7/24/2017)... ... July 24, 2017 , ... Right now, behind ... The agency is hammering out a game plan to implement changes and compromises ... to affect FDA-regulated firms. The new law:, ,     Seeks ways ...
(Date:7/24/2017)... ... , ... “A Short Walk to the Mailbox”: a remarkable memoir of an ... author, Ed Clark. Ed Clark is a church music director and choral conductor. ... of music and worship leader for over fifty years. He has a master’s ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... A ... in St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly ... of the disease offers very few benefits. , In the cases involved with ...
Breaking Medicine News(10 mins):